Annual Current Liabilities
$1.10 M
+$831.70 K+310.68%
August 31, 2024
Summary
- As of February 26, 2025, LEXX annual total current liabilities is $1.10 million, with the most recent change of +$831.70 thousand (+310.68%) on August 31, 2024.
- During the last 3 years, LEXX annual current liabilities has risen by +$946.10 thousand (+617.16%).
- LEXX annual current liabilities is now -45.43% below its all-time high of $2.01 million, reached on October 31, 2006.
Performance
LEXX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$297.80 K
-$801.60 K-72.91%
November 30, 2024
Summary
- As of February 26, 2025, LEXX quarterly total current liabilities is $297.80 thousand, with the most recent change of -$801.60 thousand (-72.91%) on November 30, 2024.
- Over the past year, LEXX quarterly current liabilities has stayed the same.
- LEXX quarterly current liabilities is now -85.22% below its all-time high of $2.01 million, reached on October 31, 2006.
Performance
LEXX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
LEXX Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +310.7% | 0.0% |
| 3 y3 years | +617.2% | +5.8% |
| 5 y5 years | +495.9% | +5.8% |
LEXX Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +617.2% | -72.9% | +264.5% |
| 5 y | 5-year | at high | +617.2% | -72.9% | +370.5% |
| alltime | all time | -45.4% | +9716.1% | -85.2% | +1467.4% |
Lexaria Bioscience Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Nov 2024 | - | $297.80 K(-72.9%) |
| Aug 2024 | $1.10 M(+310.7%) | $1.10 M(+604.7%) |
| May 2024 | - | $156.00 K(+90.9%) |
| Feb 2024 | - | $81.70 K(-34.4%) |
| Nov 2023 | - | $124.50 K(-53.5%) |
| Aug 2023 | $267.70 K(+38.0%) | $267.70 K(-74.6%) |
| May 2023 | - | $1.06 M(+373.3%) |
| Feb 2023 | - | $223.10 K(-20.7%) |
| Nov 2022 | - | $281.50 K(+45.1%) |
| Aug 2022 | $194.00 K(+26.5%) | $194.00 K(-6.2%) |
| May 2022 | - | $206.80 K(+25.0%) |
| Feb 2022 | - | $165.50 K(-30.4%) |
| Nov 2021 | - | $237.70 K(+55.1%) |
| Aug 2021 | $153.30 K(-32.1%) | $153.30 K(-30.7%) |
| May 2021 | - | $221.20 K(-44.6%) |
| Feb 2021 | - | $399.40 K(+64.7%) |
| Nov 2020 | - | $242.50 K(+7.3%) |
| Aug 2020 | $225.90 K(+22.4%) | $225.90 K(+148.2%) |
| May 2020 | - | $91.00 K(+43.8%) |
| Feb 2020 | - | $63.30 K(-51.4%) |
| Nov 2019 | - | $130.20 K(-29.4%) |
| Aug 2019 | $184.50 K(+323.2%) | $184.50 K(+39.5%) |
| May 2019 | - | $132.30 K(-73.5%) |
| Feb 2019 | - | $500.10 K(+285.0%) |
| Nov 2018 | - | $129.90 K(+197.9%) |
| Aug 2018 | $43.60 K(-52.8%) | $43.60 K(-39.1%) |
| May 2018 | - | $71.60 K(+3.8%) |
| Feb 2018 | - | $69.00 K(-27.9%) |
| Nov 2017 | - | $95.70 K(+3.7%) |
| Aug 2017 | $92.30 K(-78.7%) | $92.30 K(+130.8%) |
| May 2017 | - | $40.00 K(-88.0%) |
| Feb 2017 | - | $333.50 K(-28.8%) |
| Nov 2016 | - | $468.60 K(+8.0%) |
| Aug 2016 | $433.90 K(+687.5%) | $433.90 K(+30.9%) |
| May 2016 | - | $331.50 K(+16.6%) |
| Feb 2016 | - | $284.30 K(+60.3%) |
| Nov 2015 | - | $177.40 K(+222.0%) |
| Aug 2015 | $55.10 K | $55.10 K(-12.0%) |
| May 2015 | - | $62.60 K(+64.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Feb 2015 | - | $38.10 K(-95.2%) |
| Nov 2014 | - | $789.40 K(-17.5%) |
| Aug 2014 | $918.00 K(-35.1%) | - |
| Jul 2014 | - | $957.40 K(-8.4%) |
| Apr 2014 | - | $1.05 M(-29.0%) |
| Jan 2014 | - | $1.47 M(+4.1%) |
| Oct 2013 | $1.42 M(-17.3%) | $1.42 M(+1.2%) |
| Jul 2013 | - | $1.40 M(-5.4%) |
| Apr 2013 | - | $1.48 M(-4.9%) |
| Jan 2013 | - | $1.55 M(-9.1%) |
| Oct 2012 | $1.71 M(+58.7%) | $1.71 M(-6.8%) |
| Jul 2012 | - | $1.84 M(+1.4%) |
| Apr 2012 | - | $1.81 M(+8.0%) |
| Jan 2012 | - | $1.68 M(+55.4%) |
| Oct 2011 | $1.08 M(+2.8%) | $1.08 M(+23.0%) |
| Jul 2011 | - | $876.70 K(-10.6%) |
| Apr 2011 | - | $980.60 K(+0.8%) |
| Jan 2011 | - | $972.80 K(-7.3%) |
| Oct 2010 | $1.05 M(+1.8%) | $1.05 M(-7.8%) |
| Jul 2010 | - | $1.14 M(+4.4%) |
| Apr 2010 | - | $1.09 M(+2.7%) |
| Jan 2010 | - | $1.06 M(+2.9%) |
| Oct 2009 | $1.03 M(+272.4%) | $1.03 M(+3929.3%) |
| Jul 2009 | - | $25.60 K(-66.3%) |
| Apr 2009 | - | $75.90 K(+299.5%) |
| Jan 2009 | - | $19.00 K(-93.1%) |
| Oct 2008 | $277.00 K(-30.9%) | $277.00 K(-64.1%) |
| Jul 2008 | - | $772.30 K(+1.5%) |
| Apr 2008 | - | $760.80 K(-14.1%) |
| Jan 2008 | - | $885.80 K(+120.9%) |
| Oct 2007 | $401.00 K(-80.1%) | $401.00 K(-22.0%) |
| Jul 2007 | - | $514.30 K(+419.0%) |
| Apr 2007 | - | $99.10 K(+378.7%) |
| Jan 2007 | - | $20.70 K(-99.0%) |
| Oct 2006 | $2.01 M(>+9900.0%) | $2.01 M(+8365.1%) |
| Jul 2006 | - | $23.80 K(-16.2%) |
| Apr 2006 | - | $28.40 K(+6.0%) |
| Jan 2006 | - | $26.80 K |
| Oct 2005 | $11.20 K | - |
FAQ
- What is Lexaria Bioscience annual total current liabilities?
- What is the all time high annual current liabilities for Lexaria Bioscience?
- What is Lexaria Bioscience annual current liabilities year-on-year change?
- What is Lexaria Bioscience quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Lexaria Bioscience?
- What is Lexaria Bioscience quarterly current liabilities year-on-year change?
What is Lexaria Bioscience annual total current liabilities?
The current annual current liabilities of LEXX is $1.10 M
What is the all time high annual current liabilities for Lexaria Bioscience?
Lexaria Bioscience all-time high annual total current liabilities is $2.01 M
What is Lexaria Bioscience annual current liabilities year-on-year change?
Over the past year, LEXX annual total current liabilities has changed by +$831.70 K (+310.68%)
What is Lexaria Bioscience quarterly total current liabilities?
The current quarterly current liabilities of LEXX is $297.80 K
What is the all time high quarterly current liabilities for Lexaria Bioscience?
Lexaria Bioscience all-time high quarterly total current liabilities is $2.01 M
What is Lexaria Bioscience quarterly current liabilities year-on-year change?
Over the past year, LEXX quarterly total current liabilities has changed by $0.00 (0.00%)